Simony-Lafontaine J - Search Results

1

p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis.

Lopez-Crapez E, Bibeau F, Thézenas S, Ychou M, Simony-Lafontaine J, Thirion A, Azria D, Grenier J, Senesse P. Lopez-Crapez E, et al. Br J Cancer. 2005 Jun 20;92(12):2114-21. doi: 10.1038/sj.bjc.6602622. Br J Cancer. 2005. PMID: 15956964 Free PMC article.

2

p53 mutations occur in aggressive breast cancer.

Mazars R, Spinardi L, BenCheikh M, Simony-Lafontaine J, Jeanteur P, Theillet C. Mazars R, et al. Cancer Res. 1992 Jul 15;52(14):3918-23. Cancer Res. 1992. PMID: 1617667

3

Oxidant-antioxidant status alterations in cancer patients: relationship to tumor progression.

Gerber M, Astre C, Ségala C, Saintot M, Scali J, Simony-Lafontaine J, Grenier J, Pujol H. Gerber M, et al. J Nutr. 1996 Apr;126(4 Suppl):1201S-7S. doi: 10.1093/jn/126.suppl_4.1201S. J Nutr. 1996. PMID: 8642457

4

Tumor progression and oxidant-antioxidant status.

Gerber M, Astre C, Ségala C, Saintot M, Scali J, Simony-Lafontaine J, Grenier J, Pujol H. Gerber M, et al. Cancer Lett. 1997 Mar 19;114(1-2):211-4. doi: 10.1016/s0304-3835(97)04665-x. Cancer Lett. 1997. PMID: 9103294

5

[Primary angiosarcoma of the breast. Apropos of 2 cases].

Melhouf MM, Amrani N, Simony-Lafontaine J, Pujol H, Dubois JB. Melhouf MM, et al. Bull Cancer. 1997 Feb;84(2):218-22. Bull Cancer. 1997. PMID: 9180849 Review. French.

6

Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas.

Ferrières G, Cuny M, Simony-Lafontaine J, Jacquemier J, Rouleau C, Guilleux F, Grenier J, Rouanet P, Pujol H, Jeanteur P, Escot C. Ferrières G, et al. J Pathol. 1997 Oct;183(2):204-11. doi: 10.1002/(SICI)1096-9896(199710)183:2<204::AID-PATH921>3.0.CO;2-M. J Pathol. 1997. PMID: 9390034

7

Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors.

Simony-Lafontaine J, Esslimani M, Bribes E, Gourgou S, Lequeux N, Lavail R, Grenier J, Kramar A, Casellas P. Simony-Lafontaine J, et al. Br J Cancer. 2000 Jun;82(12):1958-66. doi: 10.1054/bjoc.2000.1162. Br J Cancer. 2000. PMID: 10864204 Free PMC article.

8

Oxidant-antioxidant status in relation to survival among breast cancer patients.

Saintot M, Mathieu-Daude H, Astre C, Grenier J, Simony-Lafontaine J, Gerber M. Saintot M, et al. Int J Cancer. 2002 Feb 10;97(5):574-9. doi: 10.1002/ijc.10099. Int J Cancer. 2002. PMID: 11807780

9

Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.

Rouanet P, Linares-Cruz G, Dravet F, Poujol S, Gourgou S, Simony-Lafontaine J, Grenier J, Kramar A, Girault J, Le Nestour E, Maudelonde T. Rouanet P, et al. J Clin Oncol. 2005 May 1;23(13):2980-7. doi: 10.1200/JCO.2005.06.064. J Clin Oncol. 2005. PMID: 15860853 Clinical Trial.

10

Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis.

Esslimani-Sahla M, Thezenas S, Simony-Lafontaine J, Kramar A, Lavaill R, Chalbos D, Rochefort H. Esslimani-Sahla M, et al. Int J Cancer. 2007 Jan 15;120(2):224-9. doi: 10.1002/ijc.22202. Int J Cancer. 2007. PMID: 17044016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters